Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FX301 Nerve Block for Post-surgical Pain Following Bunionectomy
NCT04826328Phase 1Completed
- Sponsor
- Pacira BioSciences
- Start
- Mar 2021
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of FX301 in postoperative pain (5 arms), sponsored by Pacira BioSciences. Primary endpoint: Incidence of Treatment Emergent Adverse Events. Started Mar 2021; status: completed.
02
Drugs
FX301
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04826328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04826328.